Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey
Author:
Dilek Semine Özdemir1ORCID, Gürbüz Fatih1ORCID, Turan İhsan1ORCID, Celiloğlu Can1ORCID, Yüksel Bilgin1ORCID
Affiliation:
1. Division of Pediatric Endocrinology , Cukurova University Faculty of Medicine , Adana , Turkey
Abstract
Abstract
Objectives
The COVID-19 pandemic is a global health problem with high morbidity and mortality. This study aimed to investigate patients who were diagnosed with type 1 diabetes during the pandemic and evaluate the effect of the pandemic on the clinical findings of these patients by comparing them with findings from a year prior.
Methods
Patients diagnosed with type 1 diabetes mellitus between 2019 and 2021 were separated into two groups: Patients diagnosed prepandemic and those diagnosed during the pandemic.
Results
The number of newly diagnosed diabetes cases increased from 46 in the prepandemic period to 74 in the pandemic period. The number of cases diagnosed with diabetic ketoacidosis (DKA) in the clinic increased from 58.7 to 91.9%. We found that moderate and severe DKA rates from 18.5 and 14.8% to 23.5 and 22.1%, respectively. Besides, the average HbA1c was higher, while the average bicarbonate was lower in cases diagnosed during the pandemic period compared to the prepandemic period (p=0.048 and p<0.001, respectively). We found that celiac autoantibody positivity antibodies to glutamic acid decarboxylase (anti GAD) positivity, and islet cell antibodies (ICA), ICA and anti GAD positivity coexistence were higher (p=0.045, p=0.008, and p=0.007, respectively) among the patients diagnosed during the pandemic.
Conclusions
We observed an increase in the number of patients newly diagnosed with type 1 diabetes mellitus, an increase in autoantibody positivity, and higher rates and severity of DKA during the COVID-19 pandemic period compared to the prepandemic period.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health
Reference48 articles.
1. Tay, MZ, Poh, CM, Rénia, L, MacAry, PA, Ng, LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363–74, https://doi.org/10.1038/s41577-020-0311-8. 2. Sohrabi, C, Alsafi, Z, O’Neill, N, Khan, M, Kerwan, A, Al-Jabir, A, et al.. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71–6, https://doi.org/10.1016/j.ijsu.2020.02.034. 3. Republic of Turkish Ministry of Health Covid-19 Information page. General Coronavirus Table. Available from: https://covid19.saglik.gov.tr/EN-69532/general-coronavirus-table.html [Accessed: 15 Apr 2021]. 4. Verma, A, Rajput, R, Verma, S, Balania, VKB, Jangra, B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab Syndr 2020;14:1213–6, https://doi.org/10.1016/j.dsx.2020.07.016. 5. Rabbone, I, Schiaffini, R, Cherubini, V, Maffeis, C, Scaramuzza, A. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care 2020;43:2870–2, https://doi.org/10.2337/dc20-1321.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|